Facilities

Swiss firm Lonza is taking its investment in China to the next level with a manufacturing upgrade to its key site in Guangdong Province.

What are the challenges and best practices in quality control for difficult-to-inspect products?

Experts from Colorcon explain how the company’s investments in facilities and new technologies are helping the pharma sector reach its goals.

How adding barcodes to glass containers can improve traceability.

Technology transfer is full of risks. But risks can be mitigated with the right strategy.

Let’s reduce the impact of pharmaceutical effluent on the environment.

How can the FDA tackle the inspection backlog?

We catch up with Samsung Biologics about easing tech transfers and preparing plants for the future.

Dave Tudor gives an update on CPI’s “Grand Challenges”.

Facilities must be flexible enough to cope with multiple modalities, including cell and gene therapies.